Your browser doesn't support javascript.
loading
Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.
Spampinato, Sofia; Jensen, Nina B K; Pötter, Richard; Fokdal, Lars U; Chargari, Cyrus; Lindegaard, Jacob C; Schmid, Maximilian P; Sturdza, Alina; Jürgenliemk-Schulz, Ina M; Mahantshetty, Umesh; Hoskin, Peter; Segedin, Barbara; Rai, Bhavana; Bruheim, Kjersti; Wiebe, Ericka; Van der Steen-Banasik, Elzbieta; Cooper, Rachel; Van Limbergen, Erik; Sundset, Marit; Pieters, Bradley R; Lutgens, Ludy C H W; Tan, Li Tee; Villafranca, Elena; Smet, Stéphanie; Jastaniyah, Noha; Nout, Remi A; Kirisits, Christian; Chopra, Supriya; Kirchheiner, Kathrin; Tanderup, Kari.
Afiliação
  • Spampinato S; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. Electronic address: sofspa@rm.dk.
  • Jensen NBK; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Pötter R; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Fokdal LU; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Chargari C; Department of Radiotherapy, Gustave-Roussy, Villejuif, France.
  • Lindegaard JC; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Schmid MP; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Sturdza A; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Jürgenliemk-Schulz IM; Department of Radiation Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Mahantshetty U; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai and Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, India.
  • Hoskin P; Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, United Kingdom.
  • Segedin B; Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia, Faculty of Medicine, University of Ljubljana.
  • Rai B; Department of Radiotherapy and Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Bruheim K; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Wiebe E; Department of Oncology, Cross Cancer Institute and University of Alberta, Edmonton, Canada.
  • Van der Steen-Banasik E; Department of Radiotherapy, Radiotherapiegroep Arnhem, Arnhem, The Netherlands.
  • Cooper R; Leeds Cancer Centre, St James's University Hospital, Leeds, United Kingdom.
  • Van Limbergen E; Department of Radiation Oncology, University Hospital Leuven, Leuven, Belgium.
  • Sundset M; Clinic of Oncology and Women's Clinic, St. Olavs Hospital, Trondheim, Norway.
  • Pieters BR; Department of Radiation Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Lutgens LCHW; Maastricht Radiation Oncology (MAASTRO) clinic, Maastricht, The Netherlands.
  • Tan LT; Oncology Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Villafranca E; Department of Radiation Oncology, Hospital of Navarra, Pamplona, Spain.
  • Smet S; Department of Radiation Oncology, Algemeen Ziekenhuis Turnhout, Turnhout, Belgium.
  • Jastaniyah N; Radiation Oncology Section, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
  • Nout RA; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kirisits C; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Chopra S; Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Navi Mumbai, India.
  • Kirchheiner K; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Tanderup K; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Embrace Collaborative Group; See Supplementary Materials.
Int J Radiat Oncol Biol Phys ; 112(3): 681-693, 2022 03 01.
Article em En | MEDLINE | ID: mdl-34678431
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Braquiterapia / Neoplasias do Colo do Útero Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Braquiterapia / Neoplasias do Colo do Útero Tipo de estudo: Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article